Market Cap 1.65B
Revenue (ttm) 0.00
Net Income (ttm) -144.74M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,084,700
Avg Vol 1,119,916
Day's Range N/A - N/A
Shares Out 111.19M
Stochastic %K 8%
Beta -0.11
Analysts Strong Sell
Price Target $23.30

Company Profile

Amylyx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States. It provides Avexitide, an investigational, first-in-class glucagon-like peptide-1, or GLP-1 receptor antagonist, which is in phase 3 clinical trial to treat post-bariatric hypoglycemia and congenital hyperinsulinism. The company also develops AMX0035, an oral, fixed-dose combination of so...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 617 682 0917
Website: amylyx.com
Address:
55 Cambridge Parkway, Suite 6W, Cambridge, United States
ajmore
ajmore May. 13 at 11:27 AM
$AMLX Fireside chat at BofA 2026 Health Care Conference today at 1.40pm PT in Las Vegas! On June 10th, at Goldman Sachs Annual Global Healthcare Conference at 10.40 am ET in Miami.
0 · Reply
ajmore
ajmore May. 12 at 4:36 PM
$AMLX wanted to add that you probably noticed that the class action dropped! it was settle two weeks ago. little money which most will be paid by our liability policy. When it rains gold! look for shares and calls.
1 · Reply
ajmore
ajmore May. 12 at 4:33 PM
$AMLX presenting this week at bofa healthcase conf (fireside chat). In June presenting at European Conf for ALS. OLE program and EAP are running very well. the drug works! hold on to your goodies. Increase if your position is still small. Target 40. ( On good ALS data 70-100)
0 · Reply
SilentBull69
SilentBull69 May. 12 at 2:46 PM
$AMLX The bids are three times the ask here …but yet they still keep it down 😡😡
0 · Reply
LoveRetailFroth
LoveRetailFroth May. 12 at 1:48 PM
$REPL Good Morning 💎s $AMLX $SMMT $SANA $RXRX
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser May. 12 at 4:30 AM
$AMLX RSI: 21.35, MACD: -0.1199 Vol: 1.00, MA20: 16.59, MA50: 15.40 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
1 · Reply
SilentBull69
SilentBull69 May. 11 at 4:12 PM
$JBLU $NCLH $CCL $AMLX  it should be made ILLEGAL FOR INSTITUTIONAL INVESTORS TO LEND OUT THEIR SHARES FOR SHORT SELLERS IMO ,…institutional holders should not be allowed to lend out their shares so the hedge funds and MMS con just short the the living sh*t out of the very stocks that they are invested in It’s not right that they profit on both ends while retail suffers because of their greed Lending out their shares should absolutely be terminated in order for our stock market to have any reasonable chance of being fair towards retail investors It’s already corrupt enough, where they use their algorithms and their coding for trigger words …so that these hedge funds can just dump the shareprice at Will Company fundamentals do NOT drive the stock market anymore …what drives it ,..is greed from hedge funds and market makers and banks  ..AND CORRUPT MEDIA OUTLETS ON THEIR PAYROLL  
1 · Reply
Daedal
Daedal May. 11 at 2:21 PM
$AMLX Goldman pt $23 fwiw
0 · Reply
LoveRetailFroth
LoveRetailFroth May. 11 at 1:29 PM
$SMMT Good Morning 💎 s ☕️ . $AMLX $SANA $RXRX $REPL
0 · Reply
Daedal
Daedal May. 11 at 12:42 PM
$AMLX Shaking the tree.
1 · Reply
Latest News on AMLX
Amylyx sees cash runway into 2028

2026-05-07T16:21:43.000Z - 5 days ago

Amylyx sees cash runway into 2028


Amylyx Pharmaceuticals Earnings Call Transcript: Q1 2026

May 7, 2026, 8:00 AM EDT - 6 days ago

Amylyx Pharmaceuticals Earnings Call Transcript: Q1 2026


Amylyx announces launch of U.S. EAP for adults with PBH

2026-05-05T11:36:12.000Z - 8 days ago

Amylyx announces launch of U.S. EAP for adults with PBH


Amylyx price target raised to $21 from $19 at Mizuho

2026-04-28T10:58:40.000Z - 15 days ago

Amylyx price target raised to $21 from $19 at Mizuho


Amylyx price target raised to $30 from $25 at Guggenheim

2026-03-19T10:50:43.000Z - 7 weeks ago

Amylyx price target raised to $30 from $25 at Guggenheim


Amylyx price target raised to $34 from $28 at H.C. Wainwright

2026-03-04T14:38:10.000Z - 2 months ago

Amylyx price target raised to $34 from $28 at H.C. Wainwright


Amylyx files automatic mixed securities shelf

2026-03-03T13:12:32.000Z - 2 months ago

Amylyx files automatic mixed securities shelf


Amylyx Pharmaceuticals Earnings Call Transcript: Q4 2025

Mar 3, 2026, 8:00 AM EST - 2 months ago

Amylyx Pharmaceuticals Earnings Call Transcript: Q4 2025


Amylyx reports Q4 EPS (30c), consensus (34c)

2026-03-03T12:37:16.000Z - 2 months ago

Amylyx reports Q4 EPS (30c), consensus (34c)


Amylyx initiated with a Buy at Stifel

2026-03-02T21:11:21.000Z - 2 months ago

Amylyx initiated with a Buy at Stifel


Amylyx price target raised to $19 from $15 at BofA

2026-02-20T12:26:13.000Z - 2 months ago

Amylyx price target raised to $19 from $15 at BofA


Amylyx price target raised to $19 from $18 at Mizuho

2026-02-19T12:36:40.000Z - 2 months ago

Amylyx price target raised to $19 from $18 at Mizuho


Amylyx price target raised to $19 from $18 at Mizuho

2026-02-19T12:29:43.000Z - 2 months ago

Amylyx price target raised to $19 from $18 at Mizuho


Amylyx price target raised to $28 from $20 at H.C. Wainwright

2026-02-10T11:19:36.000Z - 3 months ago

Amylyx price target raised to $28 from $20 at H.C. Wainwright


Amylyx selects AMX0318 as development candidate for PBH

2026-01-08T12:16:47.000Z - 4 months ago

Amylyx selects AMX0318 as development candidate for PBH


Amylyx price target lowered to $15 from $16 at BofA

2025-12-19T14:11:21.000Z - 5 months ago

Amylyx price target lowered to $15 from $16 at BofA


Amylyx price target raised to $18 from $16 at Mizuho

2025-11-10T12:31:55.000Z - 6 months ago

Amylyx price target raised to $18 from $16 at Mizuho


Amylyx price target raised to $20 from $16 at H.C. Wainwright

2025-11-07T13:05:38.000Z - 6 months ago

Amylyx price target raised to $20 from $16 at H.C. Wainwright


Amylyx Pharmaceuticals Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:00 AM EST - 6 months ago

Amylyx Pharmaceuticals Earnings Call Transcript: Q3 2025


Amylyx price target raised to $16 from $12 at Mizuho

2025-10-29T12:51:13.000Z - 7 months ago

Amylyx price target raised to $16 from $12 at Mizuho


Amylyx Pharmaceuticals Earnings Call Transcript: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 9 months ago

Amylyx Pharmaceuticals Earnings Call Transcript: Q2 2025


Amylyx Pharmaceuticals Transcript: Status Update

Jul 13, 2025, 9:00 PM EDT - 10 months ago

Amylyx Pharmaceuticals Transcript: Status Update


Amylyx Pharmaceuticals Earnings Call Transcript: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Amylyx Pharmaceuticals Earnings Call Transcript: Q1 2025


ajmore
ajmore May. 13 at 11:27 AM
$AMLX Fireside chat at BofA 2026 Health Care Conference today at 1.40pm PT in Las Vegas! On June 10th, at Goldman Sachs Annual Global Healthcare Conference at 10.40 am ET in Miami.
0 · Reply
ajmore
ajmore May. 12 at 4:36 PM
$AMLX wanted to add that you probably noticed that the class action dropped! it was settle two weeks ago. little money which most will be paid by our liability policy. When it rains gold! look for shares and calls.
1 · Reply
ajmore
ajmore May. 12 at 4:33 PM
$AMLX presenting this week at bofa healthcase conf (fireside chat). In June presenting at European Conf for ALS. OLE program and EAP are running very well. the drug works! hold on to your goodies. Increase if your position is still small. Target 40. ( On good ALS data 70-100)
0 · Reply
SilentBull69
SilentBull69 May. 12 at 2:46 PM
$AMLX The bids are three times the ask here …but yet they still keep it down 😡😡
0 · Reply
LoveRetailFroth
LoveRetailFroth May. 12 at 1:48 PM
$REPL Good Morning 💎s $AMLX $SMMT $SANA $RXRX
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser May. 12 at 4:30 AM
$AMLX RSI: 21.35, MACD: -0.1199 Vol: 1.00, MA20: 16.59, MA50: 15.40 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
1 · Reply
SilentBull69
SilentBull69 May. 11 at 4:12 PM
$JBLU $NCLH $CCL $AMLX  it should be made ILLEGAL FOR INSTITUTIONAL INVESTORS TO LEND OUT THEIR SHARES FOR SHORT SELLERS IMO ,…institutional holders should not be allowed to lend out their shares so the hedge funds and MMS con just short the the living sh*t out of the very stocks that they are invested in It’s not right that they profit on both ends while retail suffers because of their greed Lending out their shares should absolutely be terminated in order for our stock market to have any reasonable chance of being fair towards retail investors It’s already corrupt enough, where they use their algorithms and their coding for trigger words …so that these hedge funds can just dump the shareprice at Will Company fundamentals do NOT drive the stock market anymore …what drives it ,..is greed from hedge funds and market makers and banks  ..AND CORRUPT MEDIA OUTLETS ON THEIR PAYROLL  
1 · Reply
Daedal
Daedal May. 11 at 2:21 PM
$AMLX Goldman pt $23 fwiw
0 · Reply
LoveRetailFroth
LoveRetailFroth May. 11 at 1:29 PM
$SMMT Good Morning 💎 s ☕️ . $AMLX $SANA $RXRX $REPL
0 · Reply
Daedal
Daedal May. 11 at 12:42 PM
$AMLX Shaking the tree.
1 · Reply
SilentBull69
SilentBull69 May. 8 at 7:45 PM
$AMLX I guess these institutions invested here are just gonna keep lending out their shares until the shorts beat the live sh*t out of the stock Fuc every one of you institutional holders that do this …you greedy motherfucers 
0 · Reply
LoveRetailFroth
LoveRetailFroth May. 8 at 7:27 PM
$REPL I bought this @ 3.93 bought $AMLX @ 3.92! ALS . I bought $SMMT @ 15.20 All 💎 s 🤑🚀🍺
0 · Reply
LoveRetailFroth
LoveRetailFroth May. 8 at 5:38 PM
$REPL Added 10k. 30k 💪! Let’s go ! Another $AMLX $SMMT 🍺
0 · Reply
SilentBull69
SilentBull69 May. 8 at 2:16 PM
$AMLX  Why we drop on such low volume 🤔 Because the whole damn system is rigged against retail The institutional investors have the shares, but then they turn right around and lend them out to the fucing short sellers and collect a fee meanwhile, retail suffers. And the damn algorithms sell these shares in a split second dropping the price … when the BUY pressure is higher than the SELL pressure So They Get Paid TWICE They get the long-term gain of the stock, PLUS they collect daily interest and loan fees from the fucing short sellers😡 It’s all complete bullsh*t As the short seller takes those borrowed shares and dump them on the market to drive the price down …as..”we” the retail, then watch our account values DROP because of a sell-off that was fueled by the very fucing institution that are SUPOSED to be OUR long partners in the stock They’re just handing the short sellers a fucing hammer to smash my windows, and then charging them a fee for the rental of the hammer😡😡😡
0 · Reply
LoveRetailFroth
LoveRetailFroth May. 8 at 1:11 PM
$AMLX Good Morning ☕️ $SMMT $SANA $RXRX
0 · Reply
topstockalerts
topstockalerts May. 8 at 12:18 PM
Pre Market Top Gainers PT2 $FLNC $AKAM $MASK.X $AMLX $FROG
0 · Reply
SilentBull69
SilentBull69 May. 7 at 5:21 PM
$AMLX Yeah, makes perfect sense. Let’s crash The stock on 300,000 volume with 96% of the shares owned by institutions that aren’t selling. 🤔
0 · Reply
ajmore
ajmore May. 7 at 2:45 PM
$AMLX just grab any calls! when its raining gold... Eli Lilly raised 9bln last night for acquisitions... they want to diversify. GLP-1 antagonist (avexitide) and ASO (amlx0114) are potentially on their shopping list.
1 · Reply
SilentBull69
SilentBull69 May. 7 at 2:20 PM
$AMLX WTF
0 · Reply
LoveRetailFroth
LoveRetailFroth May. 7 at 12:51 PM
$SMMT Good Morning ☕️ Another $RVMD here. $AMLX $SANA $RXRX
0 · Reply
LoveRetailFroth
LoveRetailFroth May. 7 at 12:48 PM
$AMLX 🤔 Some of those million patients who having Gastric surgery could be POTENTIAL patients around the 🌍. Focus is of course 🇺🇸☕️
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 7 at 12:26 PM
$AMLX Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.37 up 11.90% YoY • Amylyx Pharmaceuticals expects to announce topline data for the LUCIDITY trial in PBH in Q3 2026, with a potential commercial launch in 2027 if approved, and believes existing capital is sufficient until 2028.
0 · Reply